Literature DB >> 29531627

A pharmacist checklist for direct oral anticoagulant management: Raising the bar.

Kori Leblanc1,2,3,4,5,6,7,8,9,10,11,12,13,14, William M Semchuk1,2,3,4,5,6,7,8,9,10,11,12,13,14, John Papastergiou1,2,3,4,5,6,7,8,9,10,11,12,13,14, Blair Snow1,2,3,4,5,6,7,8,9,10,11,12,13,14, Leilany Mandlsohn1,2,3,4,5,6,7,8,9,10,11,12,13,14, Vinay Kapoor1,2,3,4,5,6,7,8,9,10,11,12,13,14, Lisa M Guirguis1,2,3,4,5,6,7,8,9,10,11,12,13,14, James D Douketis1,2,3,4,5,6,7,8,9,10,11,12,13,14, William Geerts1,2,3,4,5,6,7,8,9,10,11,12,13,14, David J Gladstone1,2,3,4,5,6,7,8,9,10,11,12,13,14.   

Abstract

Year:  2018        PMID： 29531627      PMCID： PMC5843121          DOI： 10.1177/1715163518756926

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  14 in total

1.  Site-level variation in and practices associated with dabigatran adherence.

Authors:  Supriya Shore; P Michael Ho; Anne Lambert-Kerzner; Thomas J Glorioso; Evan P Carey; Fran Cunningham; Lisa Longo; Cynthia Jackevicius; Adam Rose; Mintu P Turakhia
Journal:  JAMA       Date:  2015-04-14       Impact factor: 56.272

2.  How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society.

Authors:  David J Gladstone; William H Geerts; James Douketis; Noah Ivers; Jeff S Healey; Kori Leblanc
Journal:  Ann Intern Med       Date:  2015-09-01       Impact factor: 25.391

3.  Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014.

Authors:  Jeffrey I Weitz; William Semchuk; Alexander G G Turpie; William D Fisher; Cindy Kong; Antonio Ciaccia; John A Cairns
Journal:  Clin Ther       Date:  2015-10-16       Impact factor: 3.393

Review 4.  2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.

Authors:  Laurent Macle; John Cairns; Kori Leblanc; Teresa Tsang; Allan Skanes; Jafna L Cox; Jeff S Healey; Alan Bell; Louise Pilote; Jason G Andrade; L Brent Mitchell; Clare Atzema; David Gladstone; Mike Sharma; Subodh Verma; Stuart Connolly; Paul Dorian; Ratika Parkash; Mario Talajic; Stanley Nattel; Atul Verma
Journal:  Can J Cardiol       Date:  2016-09-06       Impact factor: 5.223

5.  Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Authors:  Antonio L Dans; Stuart J Connolly; Lars Wallentin; Sean Yang; Juliet Nakamya; Martina Brueckmann; Michael Ezekowitz; Jonas Oldgren; John W Eikelboom; Paul A Reilly; Salim Yusuf
Journal:  Circulation       Date:  2012-12-27       Impact factor: 29.690

6.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

7.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

8.  Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration.

Authors:  Supriya Shore; Evan P Carey; Mintu P Turakhia; Cynthia A Jackevicius; Fran Cunningham; Louise Pilote; Steven M Bradley; Thomas M Maddox; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Paul D Varosy; Preston M Schneider; Lucas N Marzec; P Michael Ho
Journal:  Am Heart J       Date:  2014-04-05       Impact factor: 4.749

9.  Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.

Authors:  David J Gladstone; Esther Bui; Jiming Fang; Andreas Laupacis; M Patrice Lindsay; Jack V Tu; Frank L Silver; Moira K Kapral
Journal:  Stroke       Date:  2008-08-28       Impact factor: 7.914

10.  Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.

Authors:  Haiyan Xu; Christian T Ruff; Robert P Giugliano; Sabina A Murphy; Francesco Nordio; Indravadan Patel; Minggao Shi; Michele Mercuri; Elliott M Antman; Eugene Braunwald
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501
View more
  2 in total

1.  Assessment of a Pharmacist-Led Direct Oral Anticoagulant Monitoring Clinic.

Authors:  Jenna Haché; Kwadwo Osei Bonsu; Rufaro Chitsike; Hai Nguyen; Stephanie Young
Journal:  Can J Hosp Pharm       Date:  2021-01-01

2.  The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways.

Authors:  Kori Leblanc; Jenny MacGillivray; Amanda Carroccia; Laurent Macle; Jason G Andrade
Journal:  Can Pharm J (Ott)       Date:  2021-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.